Beyond the U.S.: Cannabis Investors Need to Think Bigger
It’s been a year of milestones and victories for cannabis.
The industry proved its resilience in the face of a pandemic. And in turn, many American multistate operators (MSOs) are seeing their shares trade at new all-time highs.
They’re being further buoyed by the U.S. House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement Act, as well as the incoming administration.
But cannabis is a global opportunity.
It’s one that I think will reach $200 billion by the end of the decade. And there are exciting international moves being made that investors need to be aware of.
That’s why I invited PharmaCielo (OTC: PCLOF) Chief Corporate Officer David Gordon to talk about the global cannabis markets – and the exciting developments taking place – for today’s CannaBiz Now!
PharmaCielo not only is one of the largest cannabis companies in South America but also owns one of the largest cannabis operations on the planet. Its future is built around this emerging international marketplace for cannabis.
So David gives his insights into some of the significant changes in the global market that are flying under many investors’ radars.
We discuss the company’s entrance into the U.K. and what that means for PharmaCielo’s business. And David shares the challenges a producer operating out of Colombia faces versus an MSO in the U.S. or a licensed producer out of Canada.
Cannabis is not just an American or Canadian opportunity. More than two dozen countries have legalized it in some form or another. And this interview touches on what that could mean for investors.
Here’s to high returns,
What the Future Holds for the CBD Market
November 2, 2020
How Cannabis Companies Are Faring in the Wake of the Pandemic
August 18, 2020